Long Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Bipolar Disorder

por DEVRİMCİ ÖZGÜVEN, Halise, KIR, Yağmur
Publicado 2021

Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia

por Garcia-Portilla, Maria Paz, Llorca, Pierre-Michel, Maina, Giuseppe, Bozikas, Vasilis P., Devrimci-Ozguven, Halise, Kim, Sung-Wan, Bergmans, Paul, Usankova, Irina, Pungor, Katalin
Publicado 2020